Citations

Citations to this article as recorded by  

• Antifungal peptides: Therapeutic potential and challenges before their commercial success
  Anindita Sharma, Gursharan Singh, Jasvinder Singh Bhatti, Simarpreet Kaur Gill, Shailendra Kumar Arya
  International Journal of Biological Macromolecules.2025; 284: 137957.     CrossRef
• Antifungal properties of cathelicidin LL-37: current knowledge and future research directions
  Mojtaba Memariani, Hamed Memariani
  World Journal of Microbiology and Biotechnology.2024;[Epub]     CrossRef
• Candida albicans and Candida glabrata : global priority pathogens
  Myrto Katsipoulaki, Mark H. T. Stappers, Dhara Malavia-Jones, Sascha Brunke, Bernhard Hube, Neil A. R. Gow, Joseph Heitman
  Microbiology and Molecular Biology Reviews.2024;[Epub]     CrossRef
• LL-37, the master Antimicrobial Peptide, its multifaceted role from combating infections to cancer immunity
  Anand K Keshri, Suraj S Rawat, Anubha Chaudhary, Swati Sharma, Ananya Kapoor, Parul Mehra, Rimanpreet Kaur, Amit Mishra, Amit Prasad
  International Journal of Antimicrobial Agents.2024; : 107398.     CrossRef
• Recombinant production of human antimicrobial peptide LL- 37 and its secondary structure
  Antonín Pavelka, Lukáš Vacek, Adam Norek, Šárka Kobzová, Lubomír Janda
  Biologia.2023; 79(1): 263.     CrossRef
• Therapeutic Use of the Antimicrobial Peptide PNR20 to Resolve Disseminated Candidiasis in a Murine Model
  Jeisson Micelly-Moreno, Adriana Barreto-Santamaría, Gabriela Arévalo-Pinzón, Carolina Firacative, Beatriz L. Gómez, Patricia Escandón, Manuel A. Patarroyo, Julián E. Muñoz
  Journal of Fungi.2023; 9(12): 1149.     CrossRef
• Probing Cell‐Surface Interactions in Fungal Cell Walls by High‐Resolution 1H‐Detected Solid‐State NMR Spectroscopy
  Adil Safeer, Fleur Kleijburg, Salima Bahri, David Beriashvili, Edwin J. A. Veldhuizen, Jacq van Neer, Martin Tegelaar, Hans de Cock, Han A. B. Wösten, Marc Baldus
  Chemistry – A European Journal.2023;[Epub]     CrossRef
• Sources of Antifungal Drugs
  Giel Vanreppelen, Jurgen Wuyts, Patrick Van Dijck, Paul Vandecruys
  Journal of Fungi.2023; 9(2): 171.     CrossRef
• A pilot study on ultrashort peptide with fluconazole: A promising novel anticandidal combination
  Rula M. Darwish, Ali H. Salama
  Veterinary World.2023; : 1284.     CrossRef
• Antimicrobial peptide LL-37 disrupts plasma membrane and calcium homeostasis in Candida albicans via the Rim101 pathway
  Sheng-Yuan Chen, Che-Kang Chang, Chung-Yu Lan, Rebecca S. Shapiro
  Microbiology Spectrum.2023;[Epub]     CrossRef
• Antimicrobial Peptides: Avant-Garde Antifungal Agents to Fight against Medically Important Candida Species
  Gina P. Rodríguez-Castaño, Frank Rosenau, Ludger Ständker, Carolina Firacative
  Pharmaceutics.2023; 15(3): 789.     CrossRef
• The Role of Sfp1 in Candida albicans Cell Wall Maintenance
  Che-Kang Chang, Min-Chi Yang, Hsueh-Fen Chen, Yi-Ling Liao, Chung-Yu Lan
  Journal of Fungi.2022; 8(11): 1196.     CrossRef
• In Vitro Antifungal Activity of LL-37 Analogue Peptides against Candida spp.
  Gladys Pinilla, Yenifer Tatiana Coronado, Gabriel Chaves, Liliana Muñoz, Jeannette Navarrete, Luz Mary Salazar, Carlos Pelleschi Taborda, Julián E. Muñoz
  Journal of Fungi.2022; 8(11): 1173.     CrossRef
• Antimicrobial Peptides with Anti-Candida Activity
  Aitzol Perez-Rodriguez, Elena Eraso, Guillermo Quindós, Estibaliz Mateo
  International Journal of Molecular Sciences.2022; 23(16): 9264.     CrossRef
• Bacillus Metabolites: Compounds, Identification and Anti-Candida albicans Mechanisms
  Weichen Wang, Jin Zhao, Zhizi Zhang
  Microbiology Research.2022; 13(4): 972.     CrossRef
• Antifungal Activity of Human Cathelicidin LL-37, a Membrane Disrupting Peptide, by Triggering Oxidative Stress and Cell Cycle Arrest in Candida auris
  Irfan A. Rather, Jamal S. M. Sabir, Amer H. Asseri, Sajad Ali
  Journal of Fungi.2022; 8(2): 204.     CrossRef
• Candida albicans Sfp1 Is Involved in the Cell Wall and Endoplasmic Reticulum Stress Responses Induced by Human Antimicrobial Peptide LL-37
  Chun-Min Hsu, Yi-Ling Liao, Che-Kang Chang, Chung-Yu Lan
  International Journal of Molecular Sciences.2021; 22(19): 10633.     CrossRef
• Targeted Delivery of Miconazole Employing LL37 Fragment Mutant Peptide CKR12-Poly (Lactic-Co-Glycolic) Acid Polymeric Micelles
  Takeshi Mori, Miyako Yoshida, Mai Hazekawa, Daisuke Ishibashi, Yoshiro Hatanaka, Rie Kakehashi, Makoto Nakagawa, Toshihiro Nagao, Miki Yoshii, Honami Kojima, Rio Uno, Takahiro Uchida
  International Journal of Molecular Sciences.2021; 22(21): 12056.     CrossRef
• Candida albicans Isolates 529L and CHN1 Exhibit Stable Colonization of the Murine Gastrointestinal Tract
  Liam D. McDonough, Animesh A. Mishra, Nicholas Tosini, Pallavi Kakade, Swathi Penumutchu, Shen-Huan Liang, Corrine Maufrais, Bing Zhai, Ying Taur, Peter Belenky, Richard J. Bennett, Tobias M. Hohl, Andrew Y. Koh, Iuliana V. Ene, Judith Berman
  mBio.2021;[Epub]     CrossRef
• Role of Atypical Chemokines and Chemokine Receptors Pathways in the Pathogenesis of COPD
  Francesco Nucera, Federica Lo Bello, Sj S. Shen, Paolo Ruggeri, Irene Coppolino, Antonino Di Stefano, Cristiana Stellato, Vincenzo Casolaro, Phil M. Hansbro, Ian M. Adcock, Gaetano Caramori
  Current Medicinal Chemistry.2021; 28(13): 2577.     CrossRef
• Immune Cell Degranulation in Fungal Host Defence
  Adley CH. Mok, Christopher H. Mody, Shu Shun Li
  Journal of Fungi.2021; 7(6): 484.     CrossRef
• Recombinant fusion protein by lysozyme and antibacterial peptide enhances ischemic wound healing via angiogenesis and reduction of inflammation in diabetic db/db mice
  Wei Li, Yu-Xin Jiang, Qing-Ying Chen, Guo-Guang Wang
  PeerJ.2021; 9: e11256.     CrossRef
• Efficacy of Cathelicidin LL-37 in an MRSA Wound Infection Mouse Model
  Oriana Simonetti, Oscar Cirioni, Gaia Goteri, Guendalina Lucarini, Elżbieta Kamysz, Wojciech Kamysz, Fiorenza Orlando, Giulio Rizzetto, Elisa Molinelli, Gianluca Morroni, Roberto Ghiselli, Mauro Provinciali, Andrea Giacometti, Annamaria Offidani
  Antibiotics.2021; 10(10): 1210.     CrossRef
• Nanoantibiotics containing membrane-active human cathelicidin LL-37 or synthetic ceragenins attached to the surface of magnetic nanoparticles as novel and innovative therapeutic tools: current status and potential future applications
  Urszula Wnorowska, Krzysztof Fiedoruk, Ewelina Piktel, Suhanya V. Prasad, Magdalena Sulik, Marianna Janion, Tamara Daniluk, Paul B. Savage, Robert Bucki
  Journal of Nanobiotechnology.2020;[Epub]     CrossRef
• Murine and Human Cathelicidins Contribute Differently to Hallmarks of Mastitis Induced by Pathogenic Prototheca bovis Algae
  Muhammad Shahid, Paloma Araujo Cavalcante, Cameron G. Knight, Herman W. Barkema, Bo Han, Jian Gao, Eduardo R. Cobo
  Frontiers in Cellular and Infection Microbiology.2020;[Epub]     CrossRef
• Interactions of GF-17 derived from LL-37 antimicrobial peptide with bacterial membranes: a molecular dynamics simulation study
  Hossein Aghazadeh, Mokhtar Ganjali Koli, Reza Ranjbar, Kamran Pooshang Bagheri
  Journal of Computer-Aided Molecular Design.2020; 34(12): 1261.     CrossRef
• Candidalysin Is a Potent Trigger of Alarmin and Antimicrobial Peptide Release in Epithelial Cells
  Jemima Ho, Don N. Wickramasinghe, Spyridoula-Angeliki Nikou, Bernhard Hube, Jonathan P. Richardson, Julian R. Naglik
  Cells.2020; 9(3): 699.     CrossRef
• Synthesis and Antimicrobial Activity of a New Drug Based on a Retro-Analog of Cathelicidin—Polypeptide SE-33
  A. S. Trenin, V. G. Arzumanian, M. N. Zhmak, I. V. Shelukhina, Ya. V. Makarova, I. A. Ivanov, O. P. Bychkova, A. S. Budikhina, L. S. Balyasova, V. I. Tsetlin
  Russian Journal of Bioorganic Chemistry.2019; 45(2): 89.     CrossRef
• The activity and action mechanism of novel short selective LL‐37‐derived anticancer peptides against clinical isolates of Escherichia coli
  Hossein Aghazadeh, Hamed Memariani, Reza Ranjbar, Kamran Pooshang Bagheri
  Chemical Biology & Drug Design.2019; 93(1): 75.     CrossRef
• Insight into the Antifungal Mechanism of Action of Human RNase N-terminus Derived Peptides
  Vivian A. Salazar, Javier Arranz-Trullén, Guillem Prats-Ejarque, Marc Torrent, David Andreu, David Pulido, Ester Boix
  International Journal of Molecular Sciences.2019; 20(18): 4558.     CrossRef
• The Human Cathelicidin Antimicrobial Peptide LL-37 Promotes the Growth of the Pulmonary Pathogen Aspergillus fumigatus
  Gerard Sheehan, Gudmundur Bergsson, Noel G. McElvaney, Emer P. Reeves, Kevin Kavanagh, George S. Deepe
  Infection and Immunity.2018;[Epub]     CrossRef
• Ceragenins are active against drug-resistant Candida auris clinical isolates in planktonic and biofilm forms
  Marjan M Hashemi, John Rovig, Brett S Holden, Maddison F Taylor, Scott Weber, John Wilson, Brian Hilton, Aaron L Zaugg, Samuel W Ellis, Connor D Yost, Patrick M Finnegan, Charles K Kistler, Elizabeth L Berkow, Shenglou Deng, Shawn R Lockhart, Marnie Peter
  Journal of Antimicrobial Chemotherapy.2018; 73(6): 1537.     CrossRef
• Estrogen reinforces barrier formation and protects against tumor necrosis factor alpha-induced barrier dysfunction in oral epithelial cells
  Yun Sik Choi, Keumjin Baek, Youngnim Choi
  Journal of Periodontal & Implant Science.2018; 48(5): 284.     CrossRef
• Characterization of bactericidal efficiency, cell selectivity, and mechanism of short interspecific hybrid peptides
  N. Dong, X. R. Li, X. Y. Xu, Y. F. Lv, Z. Y. Li, A. S. Shan, J. L. Wang
  Amino Acids.2018; 50(3-4): 453.     CrossRef
• Perspectives for clinical use of engineered human host defense antimicrobial peptides
  María Eugenia Pachón-Ibáñez, Younes Smani, Jerónimo Pachón, Javier Sánchez-Céspedes
  FEMS Microbiology Reviews.2017; 41(3): 323.     CrossRef
• Natural Antimicrobial Peptides as Inspiration for Design of a New Generation Antifungal Compounds
  Małgorzata Bondaryk, Monika Staniszewska, Paulina Zielińska, Zofia Urbańczyk-Lipkowska
  Journal of Fungi.2017; 3(3): 46.     CrossRef
• Anti-fungal activity of Ctn[15–34], the C-terminal peptide fragment of crotalicidin, a rattlesnake venom gland cathelicidin
  Carolina Sidrim P Cavalcante, Cláudio B Falcão, Raquel OS Fontenelle, David Andreu, Gandhi Rádis-Baptista
  The Journal of Antibiotics.2017; 70(3): 231.     CrossRef
• Potent in vitro and in vivo antifungal activity of a small molecule host defense peptide mimic through a membrane-active mechanism
  Lorenzo P. Menzel, Hossain Mobaswar Chowdhury, Jorge Adrian Masso-Silva, William Ruddick, Klaudia Falkovsky, Rafael Vorona, Andrew Malsbary, Kartikeya Cherabuddi, Lisa K. Ryan, Kristina M. DiFranco, David C. Brice, Michael J. Costanzo, Damian Weaver, Kati
  Scientific Reports.2017;[Epub]     CrossRef
• Potential Use of Antimicrobial Peptides as Vaginal Spermicides/Microbicides
  Nongnuj Tanphaichitr, Nopparat Srakaew, Rhea Alonzi, Wongsakorn Kiattiburut, Kessiri Kongmanas, Ruina Zhi, Weihua Li, Mark Baker, Guanshun Wang, Duane Hickling
  Pharmaceuticals.2016; 9(1): 13.     CrossRef
• Candidacidal Activity of Selected Ceragenins and Human Cathelicidin LL-37 in Experimental Settings Mimicking Infection Sites
  Bonita Durnaś, Urszula Wnorowska, Katarzyna Pogoda, Piotr Deptuła, Marzena Wątek, Ewelina Piktel, Stanisław Głuszek, Xiaobo Gu, Paul B. Savage, Katarzyna Niemirowicz, Robert Bucki, Joy Sturtevant
  PLOS ONE.2016; 11(6): e0157242.     CrossRef
• Adaptation of Candida Albicans to Commensalism in the Gut
  Daniel Prieto, Inês Correia, Jesús Pla, Elvira Román
  Future Microbiology.2016; 11(4): 567.     CrossRef
• Management of Candida Biofilms: State Of Knowledge and New Options for Prevention and Eradication
  Helena Bujdáková
  Future Microbiology.2016; 11(2): 235.     CrossRef
• Exploring the mechanisms of action of human secretory RNase 3 and RNase 7 against Candida albicans
  Vivian A. Salazar, Javier Arranz‐Trullén, Susanna Navarro, Jose A. Blanco, Daniel Sánchez, Mohammed Moussaoui, Ester Boix
  MicrobiologyOpen.2016; 5(5): 830.     CrossRef
• Inactivation of the Antifungal and Immunomodulatory Properties of Human Cathelicidin LL-37 by Aspartic Proteases Produced by the Pathogenic Yeast Candida albicans
  Maria Rapala-Kozik, Oliwia Bochenska, Marcin Zawrotniak, Natalia Wolak, Grzegorz Trebacz, Mariusz Gogol, Dominika Ostrowska, Wataru Aoki, Mitsuyoshi Ueda, Andrzej Kozik, G. S. Deepe
  Infection and Immunity.2015; 83(6): 2518.     CrossRef
• Unique features of human cathelicidinLL‐37
  Katarzyna Bandurska, Agnieszka Berdowska, Renata Barczyńska‐Felusiak, Piotr Krupa
  BioFactors.2015; 41(5): 289.     CrossRef
• OmpA Binding Mediates the Effect of Antimicrobial Peptide LL-37 on Acinetobacter baumannii
  Ming-Feng Lin, Pei-Wen Tsai, Jeng-Yi Chen, Yun-You Lin, Chung-Yu Lan, Surajit Bhattacharjya
  PLOS ONE.2015; 10(10): e0141107.     CrossRef
• Protective role of gut commensal microbes against intestinal infections
  My Young Yoon, Keehoon Lee, Sang Sun Yoon
  Journal of Microbiology.2014; 52(12): 983.     CrossRef

Citations

Citations to this article as recorded by  

• Hyphal‐associated protein expression is crucial for Candida albicans‐induced eicosanoid biosynthesis in immune cells
  Jana Schimanski, Mark S. Gresnigt, Elena Brunner, Oliver Werz, Bernhard Hube, Ulrike Garscha
  European Journal of Immunology.2024;[Epub]     CrossRef
• Can nonsteroidal anti-inflammatory drugs (NSAIDs) be repurposed for fungal infection?
  Fatemeh Babaei, Mohammadreza Mirzababaei, Alireza Tavakkoli, Marjan Nassiri-Asl, Hossein Hosseinzadeh
  Naunyn-Schmiedeberg's Archives of Pharmacology.2024; 397(1): 59.     CrossRef
• Elucidation of the mechanisms of fluconazole resistance and repurposing treatment options against urinary Candida spp. isolated from hospitalized patients in Alexandria, Egypt
  Hend Zeitoun, Rawan A. Salem, Nadia M. El-Guink, Nesrin S. Tolba, Nelly M. Mohamed
  BMC Microbiology.2024;[Epub]     CrossRef
• An integrated transcriptomic and metabolomic approach to investigate the heterogeneous Candida albicans biofilm phenotype
  Christopher Delaney, Bryn Short, Ranjith Rajendran, Ryan Kean, Karl Burgess, Craig Williams, Carol A. Munro, Gordon Ramage
  Biofilm.2023; 5: 100112.     CrossRef
• Targeting Adhesion in Fungal Pathogen Candida Albicans
  Harlei Martin, Kevin Kavanagh, Trinidad Velasco-Torrijos
  Future Medicinal Chemistry.2021; 13(3): 313.     CrossRef
• Design, synthesis and biological evaluation of a series of iron and copper chelating deferiprone derivatives as new agents active against Candida albicans
  Martina Bortolami, Fabiana Pandolfi, Antonella Messore, Daniele Rocco, Marta Feroci, Roberto Di Santo, Daniela De Vita, Roberta Costi, Paola Cascarino, Giovanna Simonetti, Luigi Scipione
  Bioorganic & Medicinal Chemistry Letters.2021; 42: 128087.     CrossRef
• Aspirin as an Antifungal-Lock Agent in Inhibition of Candidal Biofilm Formation in Surgical Catheters
  Alice Kit Ying Chan, Yiu Cheung Tsang, Chun Hung Chu, Chiu Shun Peter Tsang
  Infection and Drug Resistance.2021; Volume 14: 1427.     CrossRef
• Drug repurposing strategies in the development of potential antifungal agents
  Qian Zhang, Fangyan Liu, Meng Zeng, Yingyu Mao, Zhangyong Song
  Applied Microbiology and Biotechnology.2021; 105(13): 5259.     CrossRef
• Anti-biofilm effect by the combined action of fluconazole and acetylsalicylic acid against species of Candida parapsilosis complex
  Franz de Assis Graciano dos Santos, Melyna Chaves Leite-Andrade, Ildnay de Sousa Brandão, Adryelle Idalina da Silva Alves, Maria Daniela Silva Buonafina, Michellangelo Nunes, Luiz Nascimento de Araújo-Neto, Maria Audilene de Freitas, Fábio André Brayner,
  Infection, Genetics and Evolution.2020; 84: 104378.     CrossRef
• Diclofenac exhibits synergism with azoles against planktonic cells and biofilms of Candida tropicalis
  Raimunda Sâmia Nogueira Brilhante, Jaiane Alves Brasil, Jonathas Sales de Oliveira, Vandbergue Santos Pereira, Waldemiro de Aquino Pereira-Neto, José Júlio Costa Sidrim, Marcos Fábio Gadelha Rocha
  Biofouling.2020; 36(5): 528.     CrossRef
• Drug Repurposing Strategy against Fungal Biofilms
  Thaís Pereira de Mello, Laura Nunes Silva, Lívia de Souza Ramos, Heloísa Freire Frota, Marta Helena Branquinha, André Luis Souza dos Santos
  Current Topics in Medicinal Chemistry.2020; 20(7): 509.     CrossRef
• Aspirin alleviates orthopedic implant‑associated infection
  Yi Jiang, Sheng‑Nan Wang, Hang‑Tian Wu, Han‑Jun Qin, Ming‑Liang Ren, Jian‑Chun Lin, Bin Yu
  International Journal of Molecular Medicine.2019;[Epub]     CrossRef
• Metabolomic analysis of low and high biofilm-forming Helicobacter pylori strains
  Eric Hong Jian Wong, Chow Goon Ng, Khean Lee Goh, Jamuna Vadivelu, Bow Ho, Mun Fai Loke
  Scientific Reports.2018;[Epub]     CrossRef
• Effects of Rhodomyrtus tomentosa extract on virulence factors of Candida albicans and human neutrophil function
  Jutharat Hmoteh, Khadar Syed Musthafa, Supayang Piyawan Voravuthikunchai
  Archives of Oral Biology.2018; 87: 35.     CrossRef
• Prostaglandin E 2 Receptor Antagonist with Antimicrobial Activity against Methicillin-Resistant Staphylococcus aureus
  Mélanie A. C. Ikeh, Paul L. Fidel, Mairi C. Noverr
  Antimicrobial Agents and Chemotherapy.2018;[Epub]     CrossRef
• Oral hygiene might prevent cancer
  Oscar J. Cordero, Rubén Varela-Calviño
  Heliyon.2018; 4(10): e00879.     CrossRef
• Characterization of a novel antibiofilm effect of nitric oxide-releasing aspirin (NCX-4040) on Candida albicans isolates from denture stomatitis patients
  Francisco Madariaga-Venegas, Roberto Fernández-Soto, Luisa Fernanda Duarte, Nicole Suarez, Daniela Delgadillo, José A. Jara, Ricardo Fernández-Ramires, Blanca Urzúa, Alfredo Molina-Berríos, Sompop Bencharit
  PLOS ONE.2017; 12(5): e0176755.     CrossRef
• Potential Antifungal Targets against a Candida Biofilm Based on an Enzyme in the Arachidonic Acid Cascade—A Review
  Xinning Liu, Decai Wang, Cuixiang Yu, Tao Li, Jianqiao Liu, Shujuan Sun
  Frontiers in Microbiology.2016;[Epub]     CrossRef
• Neutrophils influx and proinflammatory cytokines inhibition by sodium salicylate, unlike aspirin, in Candida albicans-induced peritonitis model
  Priscilla Aparecida Tártari Pereira, Daniel Bini, Fernanda Bovo, Lucia Helena Faccioli, Marta Chagas Monteiro
  Folia Microbiologica.2016; 61(4): 337.     CrossRef
• New frontiers for anti-biofilm drug development
  Suzana M. Ribeiro, Mário R. Felício, Esther Vilas Boas, Sónia Gonçalves, Fabrício F. Costa, Ramar Perumal Samy, Nuno C. Santos, Octávio L. Franco
  Pharmacology & Therapeutics.2016; 160: 133.     CrossRef
• Effect of tyrosol on Staphylococcus aureus antimicrobial susceptibility, biofilm formation and virulence factors
  H Abdel Rhman Shaymaa, E Rizk Dina
  African Journal of Microbiology Research.2016; 10(20): 687.     CrossRef
• Effect of non-steroidal anti-inflammatory drugs and dexamethazone on the biofilm formation and expression of some adhesion-related genes of Candida albicans and Staphylococcus aureus
  Mahmoud Abd El Baky Rehab, G El Gendy Sherein
  African Journal of Microbiology Research.2016; 10(20): 694.     CrossRef
• The roles of CDR1, CDR2, and MDR1 in kaempferol-induced suppression with fluconazole-resistant Candida albicans
  Jing Shao, MengXiang Zhang, TianMing Wang, Yue Li, ChangZhong Wang
  Pharmaceutical Biology.2016; 54(6): 984.     CrossRef
• Potent Synergy between Spirocyclic Pyrrolidinoindolinones and Fluconazole against Candida albicans
  Ilandari Dewage Udara Anulal Premachandra, Kevin A. Scott, Chengtian Shen, Fuqiang Wang, Shelley Lane, Haoping Liu, David L. Van Vranken
  ChemMedChem.2015; 10(10): 1672.     CrossRef
• Th17 response and its regulation in inflammatory upper airway diseases
  Y. Liu, M. Zeng, Z. Liu
  Clinical & Experimental Allergy.2015; 45(3): 602.     CrossRef
• Role of Pathogen-Derived Cell Wall Carbohydrates and Prostaglandin E 2 in Immune Response and Suppression of Fish Immunity by the Oomycete Saprolegnia parasitica
  Rodrigo Belmonte, Tiehui Wang, Gary J. Duncan, Ida Skaar, Hugo Mélida, Vincent Bulone, Pieter van West, Christopher J. Secombes, J. A. Appleton
  Infection and Immunity.2014; 82(11): 4518.     CrossRef